Computational Intelligence and Neuroscience, 2020 · DOI: https://doi.org/10.1155/2020/8915961 · Published: May 20, 2020
This study explores how well EEG, MRI, and standard cognitive tests can predict cognitive decline in people with temporal lobe epilepsy (TLE) or mild cognitive impairment (MCI). The researchers used machine learning to combine these different types of data to improve prediction accuracy. The study found that combining data from EEG, MRI, and neuropsychological tests could predict changes in cognitive performance, such as executive functions, visual-verbal memory, and divided attention. This suggests a more holistic approach to understanding and predicting cognitive decline. The findings indicate that there may be common biomarkers across different neurological conditions that contribute to cognitive decline. Identifying these biomarkers could lead to more general models for predicting cognitive decline.
Combining EEG, MRI, and neuropsychological data can lead to more accurate predictions of cognitive decline, aiding in early diagnosis and intervention.
Identifying specific biomarkers associated with cognitive decline can help tailor treatment strategies to individual patients based on their unique risk profiles.
The discovery of shared predictive biomarkers across different neurological conditions could contribute to the development of more general models of cognitive decline, applicable beyond specific disease populations.